Delayed Puberty

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: The Molecular Basis of Inherited Reproductive Disorders

  Clinical trial update describing research into the molecular basis of inherited reproductive disorders, including hypogonadotropic hypogonad…

• FDA approval · 2025-07-11
  FDA Approved: TESTOSTERONE — Supplemental Application (Cipla USA Inc.)

  FDA approved a supplemental application for TESTOSTERONE from Cipla USA Inc. under an ANDA.

• FDA approval · 2025-07-11
  FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (NorthStar Rx LLC)

  FDA approved a supplemental application for Testosterone Cypionate from NorthStar Rx LLC under ANDA 215351.

• CLINICAL_TRIALS research · 2024-11-15
  Clinical Trial Update: Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism [NA]

  A clinical trial update indicates that Triptorelin is being studied for early diagnosis of hypogonadotropic hypogonadism. The trial is curre…

• CLINICAL_TRIALS trial_result · 2021-06-08
  Clinical Trial Update: Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone [Phase 2, Phase 3]

  Phase 2/3 clinical trial investigating growth hormone in children with anorexia nervosa showing severe growth velocity decrease and related …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2019-09-23
  FDA Approved: TESTOSTERONE — Original Application (Upsher-Smith Laboratories, LLC)

  FDA approved Upsher-Smith's TESTOSTERONE under an original application (ANDA) for testosterone therapy.

• FDA approval · 2019-06-27
  FDA Approved: TESTOSTERONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a supplemental application for TESTOSTERONE from Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2019-06-04
  FDA Approved: TESTOSTERONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for TESTOSTERONE submitted by Lupin Pharmaceuticals, Inc., approving changes related to this tes…

• FDA approval · 2016-10-25
  FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for testosterone submitted by Prasco Laboratories, finalizing an update to the product labeling.

• CLINICAL_TRIALS trial_result · 2014-01-13
  Clinical Trial Update: Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment

  The study describes clinical and biochemical characteristics of delayed puberty in boys and evaluates the effect of testosterone treatment; …

• FDA approval · 2012-11-19
  FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)

  The FDA approved a supplemental application for TESTOSTERONE, submitted by Prasco Laboratories.